T cell receptor (Vβ) bias in the response of rheumatoid arthritis synovial fluid T cells to connective tissue antigens

Scandinavian Journal of Rheumatology

Volumn 26, Issue 3, 1997, Pages 166-173

  Cuesta, I A ^b   Sud, S ^b   Song, Z ^b   Affholter, J A ^b   Karvonen, R L ^b   Fernandez Madrid F ^b   Wooley, P H ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Collagen; Immune response; Rheumatoid arthritis; T cell receptors; T cells

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; ARTICLE; CELL STIMULATION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; MULTIGENE FAMILY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION;

EID: 0030799969     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749709065676     Document Type: Article

References (35)

1. Stastny P. Association of the B cell alloantigen DRw4 with rheumatoid arthritis. N Eng J of Med 1978;298:869-71.
2. Janossy G, Panayi GS, Duke O, Bofill M, Poulter LW, Goldstein G. Rheumatoid arthritis: a disease of T-lymphocyte/ macrophage immunoregulation. Lancet 1981;ii:839-41.
3. Broker BM, Korthauer U, Heppt P, Weseloh G, de la Camp R, Kroczek RA, et al. Biased T cell receptor V gene usage in rheumatoid arthritis. Oligoclonal expansion of T cells expressing V alpha 2 genes in synovial fluid but not in peripheral blood. Arthritis Rheum. 1993;36:1234-43.
4. DerSimonian H, Sugita M, Glass DN, Maier AL, Weinblatt ME, Reme T, et al. Clonal V alpha 12.1 + T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med 1993;177:1623-31.
5. Pluschke G, Ricken G, Taube H, Kroninger S, Melchers I, Peter HH, et al. Biased T cell receptor V alpha region repertoire in the synovial fluid of rheumatoid arthritis patients. Eur J Immunol 1991;21:2749-54.
6. Williams WV, Kieber-Emmons T, Fang Q, Von Feldt J, Wang B, Ramanujam T, et al. Conserved motifs in rheumatoid arthritis synovial tissue T-cell receptor beta chains. DNA Cell Biol 1993;12:425-34.
7. Keystone EC, Minden M, Klock R, Poplonski L, Zalcberg J, Takadera T, et al. Structure of T cell antigen receptor beta chain in synovial fluid cells from patients with rheumatoid arthritis. Arthritis Rheum 1988;31:1555-7.
8. Dedeoglu F, Kaymaz H, Seaver N, Schluter SF, Yocum DE, Marchalonis JJ. Lack of preferential V beta usage in synovial T cells of rheumatoid arthritis patients. Immunol Res 1993; 12:12-20.
9. Struyk L, Kurnick JT, Hawes GE, Van Laar JM, Schipper R, Oksenberg JR, et al. T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. Hum Immunol 1993;37:237-51.
10. Harris ED. Mechanisms of disease: rheumatoid arthritis - pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
11. Clague RB, Firth SA, HoK PJ, Skingle J, Greenbury CL, and Webley M. Serum antibodies to type II collagen in rheumatoid arthritis: comparison of 6 immunological methods and clinical features. Ann Rheum Dis 1983;42:537-44.
12. Wooley PH, Luthra HS, O'Duffy JD, Bunch TW, Moore SB, Stuart JM. Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens 1984;23:263-9.
13. Trentham DE, Dynesius RA, Rocklin RE, and David JR. Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med 1978;299:327-32.
14. Londei M, Savill CM, Verhoef A, Brennan FM, Leech ZA, Duance V, et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA 1989;86:636-40.
15. Golds EE, Stephen IB, Esdaile JM, Strawczynski H, and Poole AR. Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a non-arthritic control population. Cell Immunol 1983;82:196-209.
16. Goodstone NJ, Hobbs RN, Ashton BA. Responses of T-cells from patients with inflammatory arthritis to human cartilage antigens. Biochem Soc Tran 1990;18:955
17. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
18. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977;146:857-68.
19. Yoo TJ, Kim SY, Stuart JM, Floyd RA, Olson GA, Cremer MA, et al. Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med 1988;168:777-82.
20. Giant TT, Mikecz K, Arzoumanian A, and Poole AR. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 1987;30:201-12.
21. Wooley PH, Siegner SW, Whalen JD, Karvonen RL, Fernandez-Madrid F. Proteoglycan-induced arthritis in BALB/c mice is dependant upon the development of autoantibodies to high density proteoglycans. Ann Rheum Dis 1992;51:983-91.
22. Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS. Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Cli Proc 1984; 59:737-43.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 Revised Criteria for the classification of Rheumatoid Arthritis. Arthritis Rheum 1988;31:315-24.
24. Karvonen RL, Fernandez-Madrid F, Lande MA, Hazlett L, Barrett R, An T, et al. Proteoglycans from osteoarthritic human articular cartilage influence type II collagen in vitro fibrillogenesis. Connect Tissue Res 1992;27:235-50.
25. Wooley PH, Seibold JR, Whalen JD, Chapdelaine JM. Pristane-induced arthritis. The immunological and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989;32:1022-30.
26. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325-9.
27. Howell MD, Diveley JP, Lundeen KA, Esty A, Winters ST, Carlo DJ, et al. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Nat Acad Sci USA 1991;88:10921-5.
28. Jenkins RN, Nikaein A, Zimmermann A, Meek K, Lipsky PE. T cell receptor V beta gene bias in rheumatoid arthritis. J Cli Invest 1993;92:2688-701.
29. Maruyama T, Saito I, Miyake S, Hashimoto H, Sato K, Yagita H, et al. A possible role of two hydrophobic amino acids in antigen recognition by synovial T cells in rheumatoid arthritis. Eur J Immunol 1993;23:2059-65.
30. Pluschke G, Ginter A, Taube H, Melchers I, Peter HH, Krawinkel U. Analysis of T cell receptor V beta regions expressed by rheumatoid synovial T lymphocytes. Immunobiology 1993;188:330-9.
31. a genes in rheumatoid arthritis. Eur J Immunol 1991;21:461-6.
32. Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154:688-700.
33. Haqqi TM, Banerjee S, Jones WL, Anderson G, Behlke MA, Loh DY, et al. Identification of T-cell receptor V beta deletion mutant mouse strain AU/ssJ (H-2q) which is resistant to collagen-induced arthritis. Immunogenetics 1989;29:180-5.
34. Banerjee S, Haqqi TM, Luthra HS, Stuart JM, David CS. Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med 1988;167: 832-9.
35. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Hafler DA, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261:1727-30.